BRISTOL MYERS SQUIBB CO - 8-K Filing
Bristol Myers Squibb reports Q3 2026 revenue of $13.1 billion and raises full-year revenue guidance to a range of $49.75B–$50.25B. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $BMY
Read the full article at SEC EDGAR
Part of the story Cloudflare Shares Surge Following Strong Q3 Results and Raised Full-Year Guidance (85 articles)